These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20632814)

  • 1. Standardisation of cardiac troponin I measurement: past and present.
    Tate JR; Bunk DM; Christenson RH; Katrukha A; Noble JE; Porter RA; Schimmel H; Wang L; Panteghini M;
    Pathology; 2010; 42(5):402-8. PubMed ID: 20632814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of troponin I measurements: an update.
    Panteghini M; Bunk DM; Christenson RH; Katrukha A; Porter RA; Schimmel H; Wang L; Tate JR;
    Clin Chem Lab Med; 2008; 46(11):1501-6. PubMed ID: 18778218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approach to standardisation of human cardiac troponin I (cTnI).
    Katrukha A; Bereznikova A; Pettersson K
    Scand J Clin Lab Invest Suppl; 1999; 230():124-7. PubMed ID: 10389210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the Advia Centaur second-generation troponin assay TnI-Ultra compared with the first-generation cTnI assay.
    van de Kerkhof D; Peters B; Scharnhorst V
    Ann Clin Biochem; 2008 May; 45(Pt 3):316-7. PubMed ID: 18482922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troponin I: an update on clinical utility and method standardization.
    Laurino JP
    Ann Clin Lab Sci; 2000 Oct; 30(4):412-21. PubMed ID: 11045766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward standardization of cardiac troponin I measurements part II: assessing commutability of candidate reference materials and harmonization of cardiac troponin I assays.
    Christenson RH; Duh SH; Apple FS; Bodor GS; Bunk DM; Panteghini M; Welch MJ; Wu AH; Kahn SE
    Clin Chem; 2006 Sep; 52(9):1685-92. PubMed ID: 16858078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved early risk stratification and diagnosis of myocardial infarction, using a novel troponin I assay concept.
    Ilva T; Eriksson S; Lund J; Porela P; Mustonen H; Pettersson K; Pulkki K; Voipio-Pulkki LM
    Eur J Clin Invest; 2005 Feb; 35(2):112-6. PubMed ID: 15667582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the troponin standard on the prevalence of acute myocardial infarction.
    Kontos MC; Fritz LM; Anderson FP; Tatum JL; Ornato JP; Jesse RL
    Am Heart J; 2003 Sep; 146(3):446-52. PubMed ID: 12947361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality specifications for biochemical markers of myocardial injury.
    Zaninotto M; Mion M; Altinier S; Forni M; Plebani M
    Clin Chim Acta; 2004 Aug; 346(1):65-72. PubMed ID: 15234637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.
    Wu AH; Smith A; Christenson RH; Murakami MM; Apple FS
    Clin Chim Acta; 2004 Aug; 346(2):211-9. PubMed ID: 15256323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved assay of cardiac troponin I is more sensitive than other assays of necrosis markers.
    Hjortshøj S; Dethlefsen C; Kristensen SR; Ravkilde J
    Scand J Clin Lab Invest; 2008; 68(2):130-3. PubMed ID: 17926199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lack of standardization of cardiac troponin I assay systems.
    Tate JR; Heathcote D; Rayfield J; Hickman PE
    Clin Chim Acta; 1999 Jun; 284(2):141-9. PubMed ID: 10451241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular modifications of troponin I and T detected in serum from patients with acute myocardial infarction].
    Atar D; Madsen LH; Labugger R; VanEyk JE
    Ugeskr Laeger; 2003 Jan; 165(2):116-20. PubMed ID: 12553091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troponin T or troponin I or CK-MB (or none?).
    Collinson PO
    Eur Heart J; 1998 Nov; 19 Suppl N():N16-24. PubMed ID: 9857934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of analytical performance of the Liaison troponin I assay.
    Pagani F; Stefini F; Chapelle JP; Lefèvre G; Graïne H; Luthe H; Engelmayer J; Panteghini M
    Clin Biochem; 2004 Sep; 37(9):750-7. PubMed ID: 15329312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.
    Peetz D; Schweigert R; Jachmann N; Post F; Schinzel H; Lackner KJ
    Clin Lab; 2006; 52(11-12):605-14. PubMed ID: 17175892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence based approach to practice guides and decision thresholds for cardiac markers.
    Christenson RH; Duh SH
    Scand J Clin Lab Invest Suppl; 1999; 230():90-102. PubMed ID: 10389207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision limit for troponin I on ADVIA:Centaur and evaluation of the analytical precision at low concentrations.
    Fortunato A; Giavarina D
    Clin Lab; 2003; 49(5-6):251-3. PubMed ID: 15285182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of the troponin 99th percentile cut-off and clinical utility of myoglobin measurement in the early management of chest pain patients admitted to the Emergency Cardiology Department.
    Amodio G; Antonelli G; Varraso L; Ruggieri V; Di Serio F
    Coron Artery Dis; 2007 May; 18(3):181-6. PubMed ID: 17429291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac troponins I and T in hemodialysis patients without acute coronary syndrome.
    Brunet P; Oddoze C; Paganelli F; Indreies M; Faure V; Opris-Saveanu A; Morange S; Portugal H; Dussol B; Berland Y
    Int J Cardiol; 2008 Sep; 129(2):205-9. PubMed ID: 17662483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.